Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ELT for CRBSI Prevention in HPN Patients
NCT02227329Phase 2Terminated
- Sponsor
- Mayo Clinic
- Start
- Jul 2014
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ethanol in catheter-related bloodstream infection (CRBSI), sponsored by Mayo Clinic. Started Jul 2014; status: terminated.
02
Drugs
ethanol
03
Conditions
catheter-related bloodstream infection (CRBSI)
Beyond the preview
Go deeper on NCT02227329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02227329.